"10.1371_journal.pone.0106189","plos one","2014-08-27T00:00:00Z","Edward G Meloni; Timothy E Gillis; Jasmine Manoukian; Marc J Kaufman","Department of Psychiatry, Harvard Medical School and McLean Hospital, Belmont, Massachusetts, United States of America","Conceived and designed the experiments: EGM MJK. Performed the experiments: EGM. Analyzed the data: JM. Contributed reagents/materials/analysis tools: TEG. Contributed to the writing of the manuscript: EGM MJK.","The authors have read the journals policy and the following authors of this manuscript have the following competing interests: Drs. Meloni and Kaufman disclose that they are co-inventors on intellectual property (provisional patent) owned by The McLean Hospital Corporation covering the therapeutic use of xenon for PTSD. Currently the patent has been converted from a provisional patent and is awaiting review by the patent office. Hence, it is in a state of patent pending. The application is PCT Application No. PCT/US13/74007 filed on December 10, 2013. This pending patent does not alter the authors adherence to all PLOS ONE policies on sharing data and materials.","2014","08","Edward G Meloni","EGM",4,TRUE,2,1,1,NA,TRUE,FALSE,FALSE,0,NA,FALSE
